VWA
IART icon

V Wealth Advisors’s Integra LifeSciences IART Stock Holding History

V Wealth Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,936
Closed -$297K – 215
2017
Q3 		$297K Hold
5,936
– – 0.15% 135
2017
Q2 		$324K Buy
+5,936
New +$283K 0.15% 126

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

V Wealth Advisors's IART Position: Q4 2017 in Review

V Wealth Advisors sold out of Integra LifeSciences (IART) in Q4 2017, closing a stake of 5,936 shares — an estimated $297K sold.

V Wealth Advisors first reported a position in IART in Q2 2017 and held it in 2 quarters. The position peaked at $324K in Q2 2017. 221 funds tracked by Wall St. Rank hold IART as of Q4 2017.

  • V Wealth Advisors reported no remaining Integra LifeSciences position as of Q4 2017 after selling out during the quarter.
  • V Wealth Advisors sold 5,936 Integra LifeSciences shares in Q4 2017, an estimated $297K.
  • V Wealth Advisors first reported a position in Integra LifeSciences in Q2 2017 and held it in 2 quarters.
  • V Wealth Advisors's Integra LifeSciences position peaked at $324K in Q2 2017.
  • 221 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2017.

Based on V Wealth Advisors's 13F filing for Q4 2017, filed 19 Jan 2018.